Company: INTS
Filing Date: 2025-03-28
Form Type: DRS
Source: 0001628279-25-000170
Chunk: 55

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-03-28
Form: DRS
Chunk 55
---
 us. We expect to deliver the securities being offered pursuant to this prospectus on or about , 2025, subject to satisfaction of certain conditions.

We have agreed to indemnify the Placement Agents against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the Placement Agents may be required to make in respect thereof.

#### Fees and Expenses
We have agreed to pay the Placement Agents an aggregate fee equal to seven percent (7.0%) of the purchase price paid by all purchasers in this offering. In addition, we have agreed to reimburse the Placement Agents for their legal fees in an amount up to $80,000 and non-accountable expenses of up to $25,000.

The following table shows the per share and total cash fees we will pay to the Placement Agents in connection with the sale of the securities pursuant to this prospectus.

|                                   |     | Per Share of 
 Common Stock 
 and          
 Accompanying 
 Common       
 Warrant      |     | Per Pre-Funded 
 Warrant and    
 Accompanying   
 Common         
 Warrant        |     | Total |
|:----------------------------------|:----|:-------------|:----|:---------------|:----|:------|
| Public offering price(1)          |     | $            |     | $              |     | $     |
| Placement Agents’ fees            |     | $            |     | $              |     | $     |
| Proceeds before expenses to us(2) |     | $            |     | $              |     | $     |

__________________

(1) The assumed combined public offering price is $ per share of Common Stock and accompanying Common Warrant and $ per Pre-Funded Warrant and accompanying Common Warrant.

(2) Does not include proceeds from the exercise of the Pre-Funded Warrants or Common Warrants in cash, if any.

We estimate the total expenses of this offering paid or payable by us, exclusive of the Placement Agents’ fee and reimbursements, will be approximately $ . After deducting the fees due to the Placement Agents and our estimated expenses in connection with this offering, we expect the net proceeds from this offering will be approximately $ million (based on an assumed combined public offering price per share of Common Stock and accompanying Common Warrant of $ , which was the last reported sales price of the Common Stock on the Nasdaq Capital Market on , 2025).

#### Lock-Up Agreements
Our directors and officers have entered into lock-up agreements. Under these agreements, these individuals